BEIGENE, LTD. AMENDMENT NO. 1 TO SHARE PURCHASE AGREEMENTShare Purchase Agreement • January 8th, 2020 • Amgen Inc • Biological products, (no disgnostic substances) • New York
THIS AMENDMENT NO. 1 (this “Amendment”) to the SHARE PURCHASE AGREEMENT, dated as of October 31, 2019 (the “Agreement”), is made and entered into as of December 6, 2019, by and among BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Agreement.
Certain information (indicated by “[***]”) and schedules have been excluded from this agreement because such information (i) is not material and (ii) would be competitively harmful if publicly disclosed. SHARE PURCHASE AGREEMENT By and Between Amgen...Share Purchase Agreement • January 8th, 2020 • Amgen Inc • Biological products, (no disgnostic substances) • New York
THIS SHARE PURCHASE AGREEMENT (the “Agreement”) is made and entered into as of October 31, 2019 (the “Signing Date”), by and between BeiGene, Ltd., an exempted company incorporated in the Cayman Islands (the “Company”), and Amgen Inc., a Delaware corporation (the “Investor”).
